Skip to content

Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial

Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029578
Enrollment
Unknown
Registered
2020-02-05
Start date
2020-02-06
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Treatment group:Integrated Traditional Chinese and Western Medicine

Sponsors

Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of the fifth edition of pneumonia diagnosis and treatment plan for new coronavirus infection issued by the national health and health commission (annex 1) for the confirmed cases of light (medical observation period), common (early stage of TCM clinical treatment) or heavy (middle stage of TCM clinical treatment); 2. Prospective study patients informed and consented to participate in this study.

Exclusion criteria

Exclusion criteria: Patients with other serious organ diseases or mental illness.

Design outcomes

Primary

MeasureTime frame
Cure rate;The cure time;The rate and time at which the normal type progresses to the heavy type;Rate and time of progression from heavy to critical type and even death;

Secondary

MeasureTime frame
Clinical symptoms (fever, weakness, gastrointestinal discomfort, etc.) remission and remission time;Improvement of lung HRCT score;Improvement of TCM syndromes;Average length of hospital stay;Incidence of adverse events;

Countries

China

Contacts

Public ContactChengping Wen

Zhejiang Chinese Medical University

wengcp@163.com+86 571 86613587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026